OrbiMed Capital GP VII LLC: insider buys
Every open-market stock purchase reported by OrbiMed Capital GP VII LLC to the SEC on Form 4.
Total bought$35M
Purchases2
Companies2
Last purchase filedSep 23, 2026
Return on these buys-21%
OrbiMed Capital GP VII LLC has made 2 open-market purchases worth $35M in 2 companies since Jun 1, 2026, according to SEC Form 4 filings. The most recent was filed on Sep 23, 2026: 1,333,333 shares of ETRA at $15.00 (Director, 10% Owner), worth $20M. Taken together, these purchases are down 21% at the latest closing prices (split-adjusted, weighted by amount).
Companies OrbiMed Capital GP VII LLC bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| ETRA | Electra Therapeutics, Inc. | Director, 10% Owner | 1 | $20M | -46% | Sep 23 |
| QTTB | Q32 Bio Inc. | Director, 10% Owner | 1 | $15M | +11% | Jun 1 |
Get the next OrbiMed Capital GP VII LLC purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23 | ETRAElectra Therapeutics, Inc. | OrbiMed Capital GP VII LLC +2Director, 10% Owner | $20M | 1,333,333 | $15.00 | -46% | +35% | Sep 21 | SEC |
| Jun 1 | QTTBQ32 Bio Inc. | OrbiMed Capital GP VII LLC +2Director, 10% Owner | $15M | 1,875,000 | $8.00 | +11% | +115% | May 28 | SEC |